A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Kid-size doses of Pfizer’s Covid-19 vaccine appear safe and nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Full-strength Pfizer shots already are authorized for anyone 12 or older, but pediatricians and many parents are anxiously awaiting protection for younger children to stem rising infections from the extra-contagious delta variant and help keep kids in school. A Pfizer study tracked 2,268 kids in that age group who got two shots three weeks apart of either a placebo or the low-dose vaccine. Each dose was one-third the amount given to teens and adults.
That’s important information considering that hospitalizations of mostly unvaccinated children reached record levels last month.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer says COVID-19 vaccine more than 90% effective in kidsPfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing symptomatic infections in elementary school children
続きを読む »
Pfizer Says COVID-19 Vaccine More Than 90% Effective In KidsShots could begin in early November, with the first children in line fully protected by Christmas.
続きを読む »
Pfizer says COVID-19 vaccine more than 90% effective in kidsKid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators give the go-ahead. Details of Pfizer's study were posted online.
続きを読む »
Pfizer says COVID-19 vaccine more than 90% effective in kidsKid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
続きを読む »
Pfizer says its COVID-19 vaccine more than 90 percent effective in kidsA study released Friday found that kid-size doses of Pfizer’s COVID-19 vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
続きを読む »
New Zealand sets 90% vaccine target to end Covid lockdown – latest updatesNew Zealand sets 90 percent vaccination target to end lockdowns. Other Covid19 updates: 🇲🇽 Mexico's death toll rises to 285,669 💉 CDC expands booster rollout, OKs mixing shots 🇧🇷 Brazil sees 16,853 cases For more:
続きを読む »